Your browser doesn't support javascript.
loading
Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
Harris, Meredith G; Bharat, Chrianna; Glantz, Meyer D; Sampson, Nancy A; Al-Hamzawi, Ali; Alonso, Jordi; Bruffaerts, Ronny; Caldas de Almeida, José Miguel; Cia, Alfredo H; de Girolamo, Giovanni; Florescu, Silvia; Gureje, Oye; Haro, Josep Maria; Hinkov, Hristo; Karam, Elie G; Karam, Georges; Lee, Sing; Lépine, Jean-Pierre; Levinson, Daphna; Makanjuola, Victor; McGrath, John; Mneimneh, Zeina; Navarro-Mateu, Fernando; Piazza, Marina; Posada-Villa, José; Rapsey, Charlene; Tachimori, Hisateru; Ten Have, Margreet; Torres, Yolanda; Viana, Maria Carmen; Chatterji, Somnath; Zaslavsky, Alan M; Kessler, Ronald C; Degenhardt, Louisa.
Afiliación
  • Harris MG; School of Public Health, The University of Queensland, Herston, QLD, Australia.
  • Bharat C; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, QLD, Australia.
  • Glantz MD; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Sampson NA; Department of Epidemiology, Services, and Prevention Research (DESPR), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Al-Hamzawi A; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Alonso J; College of Medicine, Al-Qadisiya University, Diwaniya Governorate, Iraq.
  • Bruffaerts R; Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Caldas de Almeida JM; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain; Pompeu Fabra University (UPF), Barcelona, Spain.
  • Cia AH; Universitair Psychiatrisch Centrum-Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.
  • de Girolamo G; Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Florescu S; Anxiety Disorders Center, Buenos Aires, Argentina.
  • Gureje O; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia.
  • Haro JM; National School of Public Health, Management and Development, Bucharest, Romania.
  • Hinkov H; Department of Psychiatry, University College Hospital, Ibadan, Nigeria.
  • Karam EG; Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain.
  • Karam G; National Center of Public Health and Analyses, Sofia, Bulgaria.
  • Lee S; Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon.
  • Lépine JP; Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut, Lebanon.
  • Levinson D; Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.
  • Makanjuola V; Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Balamand University, Faculty of Medicine, Beirut, Lebanon.
  • McGrath J; Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.
  • Mneimneh Z; Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
  • Navarro-Mateu F; Hôpital Lariboisière-Fernand Widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot;INSERM UMR-S 1144, Paris, France.
  • Piazza M; Mental Health Services, Ministry of Health, Jerusalem, Israel.
  • Posada-Villa J; Department of Psychiatry, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria.
  • Rapsey C; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.
  • Tachimori H; Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.
  • Ten Have M; National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark.
  • Torres Y; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  • Viana MC; UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, IMIB-Arrixaca, CIBERESP-, Murcia, Murcia, Spain.
  • Chatterji S; Universidad Cayetano Heredia, Lima, Peru.
  • Zaslavsky AM; Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia.
  • Kessler RC; Department of Psychological Medicine, University of Otago, Dunedin School of Medicine, Otago, New Zealand.
  • Degenhardt L; National Institute of Mental Health, National Center for Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Addiction ; 114(8): 1446-1459, 2019 08.
Article en En | MEDLINE | ID: mdl-30835879
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Addiction Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Addiction Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2019 Tipo del documento: Article País de afiliación: Australia